• Aucun résultat trouvé

Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients

N/A
N/A
Protected

Academic year: 2021

Partager "Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients"

Copied!
13
0
0

Texte intégral

Loading

Figure

Fig 1. Flow chart of population of interest extracted from the Western-Normandy MS network database (n = 733)
Table 1. Characteristics of patients diagnosed with RRMS during the period [1982–2011] in Western-Normandy.
Table 2. Association between SES and access to a second-line DMT for RRMS patients.
Fig 2. Influence of SES on delay between first and second line DMT in RRMS patients. Kaplan-Meier estimates for delay to access a second-line DMT according to EDI quintiles used as SES indicator
+2

Références

Documents relatifs

Root temperature and short term accumulation of carbohydrates in two maize hydrids at early

Modélisation du mouvement des chevreuils dans un paysage bocager simulé : premiers résultats, projets Nicolas Parisey, Marcellino Palerme, Michel Goulard, Melen Leclerc,

This first contextual study in France on the role of socio-economic factors in the access to renal transplantation or patients’ survival shows that, after taking into account

Nous avons d’une part rencontré vingt cinq personnes handicapées réparties comme suit : vingt deux personnes actives (parmi lesquelles sept femmes), dont seize en emploi (parmi

Image de pi` eces Monnaie royale canadienne -- Tous droits r´ eserv´ es c

N C 2 includes relatively medium and large lesions present at both the first two time points with co-presence of USPIO and Gd, where the Gd-enhanced lesions are focal and the

Despite promising clinical trials, intravenous immunoglobulin (IVIg) therapy in relapsing-remitting multiple sclerosis has met with uncertainties that might be

In a separate study, Munkholm et al (44) described the clinical course of inflammatory bowel disease in a regional inception cohort of 373 Crohn's disease patients diagnosed